The haplotype of the growth-differentiation factor 15 gene is associated with left ventricular hypertrophy in human essential hypertension

Clinical Science

Volumn 118, Issue 2, 2010, Pages 137-145

  Wang, Xiaojian ^a   Yang, Xu ^a   Sun, Kai ^a   Chen, Jingzhou ^a   Song, Xiaodong ^a   Wang, Hu ^a   Liu, Zhe ^a   Wang, Changxin ^a   Zhang, Channa ^a   Hui, Rutai ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Blood pressure; Cardiac remodelling; Growth differentiation factor 15 (GDF15); Hypertension; Hypertrophy; Pressure overload

Indexed keywords

GROWTH DIFFERENTIATION FACTOR 15; PHENYLEPHRINE;

ADULT; ARTICLE; COMMUNITY SAMPLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GENE EXPRESSION PROFILING; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE REMODELING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION;

CROSS-SECTIONAL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GROWTH DIFFERENTIATION FACTOR 15; HAPLOTYPES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; TRANSFECTION; VENTRICULAR REMODELING;

EID: 70549092082     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20080637     Document Type: Article

References (30)

1. Vakili, B. A., Okin, P. M. and Devereux, R. B. (2001) Prognostic implications of left ventricular hypertrophy. Am. Heart J. 141, 334-341
2. Manyari, D. E. (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N. Engl. J. Med. 323, 1706-1707
3. Galderisi, M., Anderson, K. M., Wilson, P. W. and Levy, D. (1991) Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am. J. Cardiol. 68, 85-89
4. Ganau, A., Devereux, R. B., Pickering, T. G., Roman, M. J., Schnall, P. L., Santucci, S., Spitzer, M. C. and Laragh, J. H. (1990) Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension. Circulation 81, 25-36
5. Post, W. S., Larson, M. G., Myers, R. H., Galderisi, M. and Levy, D. (1997) Heritability of left ventricular mass: the Framingham Heart Study. Hypertension 30, 1025-1028
6. Tanase, H., Yamori, Y., Hansen, C. T. and Lovenberg, W. (1982) Heart size in inbred strains of rats. Part 1. Genetic determination of the development of cardiovascular enlargement in rats. Hypertension 4, 864-872
7. Bauskin, A. R., Brown, D. A., Kuffner, T., Johnen, H., Luo, X. W., Hunter, M. and Breit, S. N. (2006) Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer. Cancer Res. 66, 4983-4986
8. Kempf, T., Eden, M., Strelau, J., Naguib, M., Willenbockel, C., Tongers, J., Heineke, J., Kotlarz, D., Xu, J., Molkentin, J. D. et al. (2006) The transforming growth factor-β superfamily member growth-differentiation factor-15 protects the heart from ischemia/ reperfusion injury. Circ. Res. 98, 351-360
9. Xu, J., Kimball, T. R., Lorenz, J. N., Brown, D. A., Bauskin, A. R., Klevitsky, R., Hewett, T. E., Breit, S. N. and Molkentin, J. D. (2006) GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. Circ. Res. 98, 342-350
10. Brown, D. A., Breit, S. N., Buring, J., Fairlie, W. D., Bauskin, A. R., Liu, T. and Ridker, P. M. (2002) Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study. Lancet 359, 2159-2163
11. Wollert, K. C., Kempf, T., Peter, T., Olofsson, S., James, S., Johnston, N., Lindahl, B., Horn-Wichmann, R., Brabant, G., Simoons, M. L. et al. (2007) Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome. Circulation 115, 962-971
12. Kempf, T., von Haehling, S., Peter, T., Allhoff, T., Cicoira, M., Doehner, W., Ponikowski, P., Filippatos, G. S., Rozentryt, P., Drexler, H. et al. (2007) Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure. J. Am. Coll. Cardiol. 50, 1054-1060
13. Wollert, K. C., Kempf, T., Lagerqvist, B., Lindahl, B., Olofsson, S., Allhoff, T., Peter, T., Siegbahn, A., Venge, P., Drexler, H. and Wallentin, L. (2007) Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome. Circulation 116, 1540-1548
14. Sahn, D. J., DeMaria, A., Kisslo, J. and Weyman, A. (1978) Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58, 1072-1083
15. Devereux, R. B., Alonso, D. R., Lutas, E. M., Gottlieb, G. J., Campo, E., Sachs, I. and Reichek, N. (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am. J. Cardiol. 57, 450-458
16. Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. et al. (2006) Recommendations for chamber quantification. Eur. J. Echocardiogr. 7, 79-108
17. Ganau, A., Devereux, R. B., Roman, M. J., de Simone, G., Pickering, T. G., Saba, P. S., Vargiu, P., Simongini, I. and Laragh, J. H. (1992) Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J. Am. Coll. Cardiol. 19, 1550-1558
18. Expert Committee on the Diagnosis, Classification of Diabetes Mellitus (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20, 1183-1197
19. International HapMap Consortium (2005) A haplotype map of the human genome. Nature 437, 1299-1320
20. 2-terminal kinase activation in the heart. Cross-talk between cardiac hypertrophic signaling pathways. J. Biol. Chem. 275, 13571-13579
21. Kempf, T., Horn-Wichmann, R., Brabant, G., Peter, T., Allhoff, T., Klein, G., Drexler, H., Johnston, N., Wallentin, L. and Wollert, K. C. (2007) Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay. Clin. Chem. 53, 284-291
22. Rubattu, S., Bigatti, G., Evangelista, A., Lanzani, C., Stanzione, R., Zagato, L., Manunta, P., Marchitti, S., Venturelli, V., Bianchi, G. et al. (2006) Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. J. Am. Coll. Cardiol. 48, 499-505
23. Li, P. X., Wong, J., Ayed, A., Ngo, D., Brade, A. M., Arrowsmith, C., Austin, R. C. and Klamut, H. J. (2000) Placental transforming growth factor-β is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression. J. Biol. Chem. 275, 20127-20135
24. Tan, M., Wang, Y., Guan, K. and Sun, Y. (2000) PTGF-β, a type β transforming growth factor (TGF-β) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-β signaling pathway. Proc. Natl. Acad. Sci. U.S.A. 97, 109-114
25. Baek, S. J., Wilson, L. C. and Eling, T. E. (2002) Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53. Carcinogenesis 23, 425-434
26. Baek, S. J., Horowitz, J. M. and Eling, T. E. (2001) Molecular cloning and characterization of human nonsteroidal anti-inflammatory drug-activated gene promoter. Basal transcription is mediated by Sp1 and Sp3. J. Biol. Chem. 276, 33384-33392
27. Marinescu, V. D., Kohane, I. S. and Riva, A. (2005) MAPPER: a search engine for the computational identification of putative transcription factor binding sites in multiple genomes. BMC Bioinformatics 6, 79
28. Omori, S. A., Smale, S., O'Shea-Greenfield, A. and Wall, R. (1997) Differential interaction of nuclear factors with the leukocyte-specific pp52 promoter in B and T cells. J. Immunol. 159, 1800-1808
29. Wall, L., Destroismaisons, N., Delvoye, N. and Guy, L.-G. (1996) CAAT/ enhancer-binding proteins are involved in β-globin gene expression and are differentially expressed in murine erythroleukemia and K562 cells. J. Biol. Chem. 271, 16477-16484
30. Cardon, L. R. and Palmer, L. J. (2003) Population stratification and spurious allelic association. Lancet 361, 598-604